Skip to main content
OpenTrials
Completed

NCT Number: NCT04619511

Risk Factors for Post-ESWL and Post-ERCP Pancreatitis

The study aimed to identify risk factors for post-ERCP pancreatitis(PEP) after ESWL, and the relationship between the occurrence of post-ESWL pancreatitis and PEP.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Pancreatitis Chronic Disease Digestive System Diseases Disease Attributes ERCP ESWL Pancreatic Diseases Pancreatitis Pancreatitis, Chronic Pathologic Processes Pathological Conditions, Signs and Symptoms Risk Factors

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with chronic pancreatitis and treated with both ESWL and subsequent ERCP

Exclusion criteria

  • Patients with isolated pancreatic tail stone
  • Patients with suspected or established malignancy
  • Patients with pancreatic ascites
  • Patients attending other interventional clinical trials
  • Patients with non-correctable coagulation disorder
  • Patients with pregnancy

Treatment and study plan

Primary outcomes

  1. post endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis

    Time frame: up to 1 months

    The main outcome analyzed was the development of post-procedural pancreatitis, which was defined as clinical pancreatitis, meeting two of three the following criteria in accordance with the Revised Atlanta International consensus including pain consistent with AP; amylase or lipase more than 3 times the upper normal limit; characteristic findings on imaging.

  2. post pancreatic extracorporeal shock wave lithotripsy (ESWL) pancreatitis

    Time frame: up to 1 months

    The main outcome analyzed was the development of post-procedural pancreatitis, which was defined as clinical pancreatitis, meeting two of three the following criteria in accordance with the Revised Atlanta International consensus including pain consistent with AP; amylase or lipase more than 3 times the upper normal limit; characteristic findings on imaging.

Sponsors and collaborators

Lead sponsor

Changhai Hospital

Other

Registry information

Official study title

Risk Factors for Post-ESWL and Post-ERCP Pancreatitis in Patients With Chronic Pancreatitis

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
Nov 6, 2020
Registry last updated
Nov 6, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.